München, Germany

Emir Jelovac

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 64(Granted Patents)


Location History:

  • München, DE (2013 - 2017)
  • Munich, DE (2016 - 2023)

Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
16 patents (USPTO):

Title: Emir Jelovac: Innovator in Nebulizer Technology

Introduction

Emir Jelovac is a prominent inventor based in München, Germany. He has made significant contributions to the field of medical devices, particularly in the development of nebulizers. With a total of 16 patents to his name, Jelovac has demonstrated a commitment to innovation and improving healthcare solutions.

Latest Patents

Among his latest inventions is a nebulizer that comprises an aerosol generator, a nebulizing chamber, and an outlet. This design allows for the efficient release of aerosol into the nebulizing chamber, facilitating a high output rate through the inclusion of a wetting surface. Another notable patent is a spacer chamber for an inhaler, which features a housing chamber, a mouthpiece, and a connecting means for the inhaler. This invention includes a lever mechanism that can activate the inhaler, enhancing its usability.

Career Highlights

Emir Jelovac has worked with 3M Innovative Properties Company, where he has further honed his skills in innovation and product development. His experience in such a reputable company has allowed him to contribute to advancements in medical technology.

Collaborations

Throughout his career, Jelovac has collaborated with talented individuals such as Korbinian Schepke-Gerlach and Özcan Dönmez. These partnerships have likely enriched his work and led to the successful development of his patents.

Conclusion

Emir Jelovac stands out as a key figure in the field of nebulizer technology, with a strong portfolio of patents that reflect his innovative spirit. His contributions continue to impact the medical device industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…